Drug Shortage Report for CONSTELLA

Last updated on 2019-02-27 History
Report ID 76263
Drug Identification Number 02417170
Brand name CONSTELLA
Common or Proper name CONSTELLA 290MCG CAP 30 CA
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) Linaclotide
Strength(s) 290MCG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 290MCG CAP 30
ATC code A06AX
ATC description DRUGS FOR CONSTIPATION
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-02-14
Estimated end date 2019-03-01
Actual end date 2019-02-26
Shortage status Resolved
Updated date 2019-02-27
Company comments 72 & 145 mcg are available.
Health Canada comments
Tier 3 Status No
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-02-19 English Compare
v2 2019-02-19 French Compare
v3 2019-02-21 English Compare
v4 2019-02-21 French Compare
v5 2019-02-26 English Compare
v6 2019-02-26 French Compare
v7 2019-02-27 English Compare

Showing 1 to 7 of 7